MedPath

Effect of Shatapushpa Tail Uttarbasti & Sharpunkha Ghan Vati in the treatment of Vandhyatva (Infertility due to Anovulation)

Phase 2/3
Not yet recruiting
Conditions
Female infertility associated withanovulation. Ayurveda Condition: Female infertility,
Registration Number
CTRI/2023/07/055680
Lead Sponsor
Post Graduate Institute of Ayurved, Jodhpur, Rajasthan
Brief Summary

In randomised comparative clinical trial on 30 diagnosed vandhyatva (female Infertility) w.s.r. Anovulatory factor. Female Patients of child Bearing age (18-40yrs) having active married life minimum 1 year

and suffering from Infertility with at least 2 or more consecutive anovulatory cycles were included. Female Patients having age less than 18years and more than 40years and Congenital deformities , infectious

diseases of reproductive tract like tuberculosis, Sexually transmitted  diseases and carcinoma, DM, HIV, HTN were excluded. Group A patients were given with Sharpunkha Ghan Vati in a dose of 500 mg tds for 7 days for 2 month. Group B patients were given with Shatapushpa Tail Uttaarbasti 5 ml for 2 consecutive cycles.



Conclusion: In Nut cell, it can be concluded that Shatapushpa tail Uttarbasti is more effective compared to Sharpunkha Ghan Vati. Final conclusion of the study will be arrived at only after completion of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Patient having complaint of failure to conceive (due to Anovulation) within one or more year of regular unprotected coitus.
  • Age groups-18 to 40 years 3.Primary or secondary infertility with Anovulatory factors.
Exclusion Criteria
  • 1.Infertility due to other factor like uterine factor, cervical factor, tubal factor, peritoneal factor.
  • 2.Infertility due to abnormality in male partner.
  • 3.Patient suffering from chronic diseases like Hypertension, Diabetes mellitus, Malignancy, Thyroid disorder, Severe anaemia, Tuberculosis etc.
  • 4.Patient suffering from Hepatitis B, sexually transmitted diseases, human immunodeficiency virus (HIV).
  • 5.Congenital anatomical defect of female genital organ 6.Surgical factors like Ovarian tumour, Ovarian endometrioma, etc.
  • 7.Contraindication of Uttar Basti (like Genital tract infection, heavy bleeding, etc.).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Dominant follicle size & Endometrial thickness.Improvement in Dominant follicle size & Endometrial thickness.
Secondary Outcome Measures
NameTimeMethod
Improvement in Interval of menstrual cycle, Duration of Bleeding, Dyspareunia60 days

Trial Locations

Locations (1)

Post Graduate Institute of Ayurved ,Jodhpur, Rajasthan

🇮🇳

Jodhpur, RAJASTHAN, India

Post Graduate Institute of Ayurved ,Jodhpur, Rajasthan
🇮🇳Jodhpur, RAJASTHAN, India
Dr Kanchan Choyal
Principal investigator
7734842989
dr.kanchanchoudhary121@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.